Yu et al. reported that in a BC cell line resistant to this antiestrogen (antiestrogen-resistant MCF7/LCC9 cells), the overexpression of miR-214 sensitizes BC cells to Fulvestran through the inhibition of autophagy, by targeting UCP2 (uncoupling protein 2). The gene discussed is UCP2; the disease is breast cancer.